Behind the Scenes of PsyMed Ventures
Business Trip, a podcast about the business of psychedelics
Welcome back to Business Trip by PsyMed Ventures, a podcast about the business of psychedelics! 🍄
This episode is a special one as Greg Kubin and Matias Serebrinsky take a moment to reflect on the opportunities and challenges they have faced while building the PsyMed Ventures syndicate and venture capital fund since starting the Business Trip podcast in 2020. Their ultimate goal is to support founders who are building ethical businesses in frontier mental health technologies with the aim of ending the suffering caused by mental illnesses. This conversation offers an honest insight into raising and deploying a venture capital fund as an emerging manager.
In this episode, we discuss:
PsyMed’s approach to fundraising as an emerging fund manager
PsyMed’s portfolio construction and expanded focus areas
How a fund can help a startup’s odds of success
What’s been challenging and lessons learned
Opportunities and outlook in frontier mental health technology
Listen to the episode here, on Spotify or Apple Podcasts.
When you’re done listening, tweet at us @psymedventures to share your thoughts!
P.S. If know someone who would like Business Trip? Feel free to share the newsletter by clicking the link below and hitting the ❤️ button on this post so more people can discover it on Substack 🙏
About Us
Business Trip by PsyMed Ventures is a podcast about psychedelic startups. Each episode features a new company in the field, ranging from biotech startups developing novel compounds, to clinics and retreats for healing, to software companies building tools to power the ecosystem.
Business Trip is produced by Greg Kubin and Matias Serebrinsky — we’re partners at PsyMed Ventures, advocates of the healing powers of psychedelic medicine.
Thanks for listening,